Prothrombin gene G20210→A transition is a risk factor for cerebral venous thrombosis

Published on Sep 1, 1998in Stroke7.19
· DOI :10.1161/01.STR.29.9.1765
Karl Reuner8
Estimated H-index: 8
(Heidelberg University),
Andreas Ruf17
Estimated H-index: 17
(Heidelberg University)
+ 5 AuthorsHeinrich Patscheke18
Estimated H-index: 18
(Heidelberg University)
Sources
Abstract
Background and Purpose—It has been recently reported that a G→A transition at nucleotide position 20210 in the 3′-untranslated region of the prothrombin gene is associated with elevated plasma prothrombin levels and an increased risk of deep venous thrombosis. To date, it is unknown whether this polymorphism also represents a risk factor for cerebral venous thrombosis (CVT). Methods—Venous blood samples were collected from 45 patients with CVT and from 354 healthy blood donors as controls. A second control group consisted of 131 subjects with acute ischemic stroke or transient ischemic attack (TIA). Genomic DNA was isolated from peripheral blood leukocytes. Amplification of DNA was performed by polymerase chain reaction (PCR). The G→A transition at nucleotide position 20210 of the prothrombin gene was detected by allele-specific restriction digestion. Results—The G20210→A transition in the prothrombin gene was found in a heterozygous form in 4 of 45 patients with CVT (8.9%) and in 8 of 354 healthy control...
📖 Papers frequently viewed together
543 Citations
199617.54Blood
4 Authors (S R Poort, ..., Rogier M. Bertina)
2,704 Citations
97 Citations
References25
Newest
#1S F T M de BruijnH-Index: 1
#2Jan StamH-Index: 47
Last. Jan P. VandenbrouckeH-Index: 113
view all 4 authors...
Abstract Objective: To investigate whether users of oral contraceptives who are carriers of a hereditary prothrombotic condition (factor V Leiden mutation, protein C, S, or antithrombin deficiency) have an increased risk of cerebral sinus thrombosis. Design: Comparison of a prospective series of cases of cerebral sinus thrombosis with population data. Setting: Neurological teaching hospitals from different regions in the Netherlands (cases) and a representative sample of the non-institutionalise...
246 CitationsSource
#1B.R. BloemH-Index: 19
Last. R. M. BertinaH-Index: 1
view all 5 authors...
Superior Sagittal Sinus Thrombosis in a Patient Heterozygous for the Novel 20210 A Allele of the Pro t h rombin Gene -
21 CitationsSource
#1Valder R. Arruda (State University of Campinas)H-Index: 30
#2Joyce M. Annichino-Bizzacchi (State University of Campinas)H-Index: 26
Last. Fernando Ferreira Costa (State University of Campinas)H-Index: 48
view all 4 authors...
The prothrombin gene variant resulting form a G >A transition at position 20210 has been described as a common genetic risk factor for venous thrombosis. However. the risk for developing arterial disease is unknown. In this investigation, we studied 116 patients with venous thrombosis and 71 with arterial disease, all of whom were compared with 295 controls. Additionally, we also investigated the distribution of the prothrombin alleles among African descendents and Amazonian Indians from Brazil....
159 CitationsSource
#1Michael MakrisH-Index: 65
#2F. E. PrestonH-Index: 51
Last. G J MillerH-Index: 2
view all 9 authors...
The presence of the 20210A allele of the prothrombin (PT) gene has recently been shown to be a risk factor for venous thromboembolism. This is probably mediated through increased plasma prothrombin levels. The aim of this study was to compare the prevalence of the prothrombin 20210A allele in control subjects and in subjects with recognised thrombophilia and to establish whether the additional inheritance of the PT 20210A allele is associated with an increased risk of venous thromboembolism. 101...
155 CitationsSource
#1Ida Martinelli (University of Milan)H-Index: 64
#2Franca Franchi (University of Milan)H-Index: 19
Last. Pier Mannuccio Mannucci (University of Milan)H-Index: 122
view all 6 authors...
To the Editor : A large population-based case-control study, the Leiden Thrombophilia Study, has shown the association of two different inherited coagulation defects with venous thromboembolism: a mutation in the factor V gene (factor V:Q506), that renders activated factor V partially resistant to
62 CitationsSource
#1Bentolila SH-Index: 2
#2Ripoll LH-Index: 1
Last. Woimant FH-Index: 1
view all 5 authors...
24 Citations
#1Frits R. Rosendaal (LEI: Leiden University)H-Index: 136
#2David S. SiscovickH-Index: 9
Last. H.L. Vos (UM: University of Michigan)H-Index: 1
view all 6 authors...
Using specimens from a population-based case control study among women ages 18 to 44 years in western Washington, we assessed the relationship between carriership of a genetic clotting factor II variant (20210 G→A) and myocardial infarction (MI). The factor II variant was previously shown to be present in 1% to 2% of the population, to increase the levels of factor II, and to be associated with venous thrombotic disease. Personal interviews and blood samples were obtained from 79 women with a fi...
322 CitationsSource
#1K. P. Brown (National Health Service)H-Index: 8
#1Karen T. BrownH-Index: 55
Last. Trevor BaglinH-Index: 68
view all 5 authors...
Summary. The odds ratio for the FII 20210G/A mutation in 504 patients with venous thromboembolism compared to controls was 2.0 (95% CI 1.0‐4.0) and, for factor V Leiden, 5.8 (95% CI 3.3‐10.3). 3/504 patients were heterozygous for both mutations. None of the patients had combined natural anticoagulant deficiency and the FII 20210G/A mutation. We conclude that the FII 20210G/A mutation is present in 2.6% of the population and the relative risk of venous thromboembolism in carriers is 2.0.
150 CitationsSource
#1Andreas Hillarp (Lund University)H-Index: 30
#2Bengt Zöller (Lund University)H-Index: 39
Last. Björn Dahlbäck (Lund University)H-Index: 101
view all 4 authors...
A dimorphism in the 3'-untranslated region of the prothrombin gene (G to A transition at position 20210) has recently been reported to be associated with increases in plasma prothrombin levels and in the risk of venous thrombosis. We have examined the prothrombin dimorphism among 99 unselected outpatients with phlebography verified deep venous thrombosis, and in 282 healthy controls. The prevalence of the 20210 A allele was 7.1% (7/99) in the patient group, and 1.8% (5/282) in the healthy contro...
220 CitationsSource
#1A. M. CummingH-Index: 17
#2S. KeeneyH-Index: 10
Last. Charles R. M. HayH-Index: 35
view all 6 authors...
Summary. We have investigated the prevalence of a recently reported genetic variation in the prothrombin gene (G20210A) in patients with an objectively confirmed history of venous thrombosis. 12/219 patients (5.5%) were found to be heterozygous carriers of the 20210 A allele. The incidence of the 20210 A allele in a group of 164 healthy controls was 1.2% (allele frequency 0.61%, 95% CI 0.08‐2.19). When patients with a known alternative hereditary risk factor for venous thrombosis (factor V Leide...
154 CitationsSource
Cited By143
Newest
#1John W. Cole, Md, Ms (UMB: University of Maryland, Baltimore)
#2Christopher A. Stack (UMB: University of Maryland, Baltimore)H-Index: 1
ABSTRACT Stroke in younger adults is less common than in older adults, with approximately 10-15% of all strokes occurring in adults aged 18 to 50 years of age. The pathogenesis of stroke in younger adults requires additional considerations for several less common risk factors and etiologies. As with any stroke patient, a thorough workup including evaluations of the brain, the blood vessels of the head and neck, the heart, and basic bloodwork must be performed. On the basis of these results, as w...
Source
#1Kanika Vasudeva (Central University of Punjab)H-Index: 5
#2Anjana Munshi (Central University of Punjab)H-Index: 24
AbstractPurpose/Aim of the study: The aim of this review is to summarize the role of genetic variants affecting mean platelet volume (MPV) and platelet count (PLT) leading to higher platelet reacti...
6 CitationsSource
#2John W. ColeH-Index: 31
1 CitationsSource
#1Mackenzie Green (RHUL: Royal Holloway, University of London)H-Index: 1
#2Toby Styles (RHUL: Royal Holloway, University of London)H-Index: 1
Last. Pankaj Sharma (RHUL: Royal Holloway, University of London)H-Index: 60
view all 12 authors...
Abstract Introduction A wide variety of non-genetic and genetic factors have been shown to associate with increased risk for cerebral venous thrombosis (CVT). However, there is a paucity of risk factor data and conclusions about their impact are often conflicting. Herein, we quantified the associations of non-genetic and genetic risk factors for CVT in adults. Materials and methods Electronic databases were searched up to January 2017. Meta-analyses were performed (RevMan v5.3) to determine pool...
13 CitationsSource
#1Zehra Narli Ozdemir (Ankara University)H-Index: 3
#2Ugur Sahin (Ankara University)H-Index: 69
Last. Osman Ilhan (Ankara University)H-Index: 25
view all 4 authors...
Inherited and/or acquired thrombophilic defects can result in venous or arterial thrombosis. This case report describes arterial thrombotic episodes triggered by the ingestion of an aphrodisiac remedy containing cantharidin in a 46-year-old female patient later discovered to be heterozygous for prothrombin G20210A mutation and seropositive for anti-β2 glycoprotein-I (anti-β2-GPI) antibodies of IgA isotype.
Source
#1Jayantee KalitaH-Index: 43
#2Usha K. MisraH-Index: 63
Last. Rajesh K SinghH-Index: 5
view all 3 authors...
We report the burden of risk factors in cerebral venous sinus thrombosis (CVST) and its relationship with the clinical severity, extent of MRI and MRV abnormality, and outcome. One hundred and twenty-eight consecutive patients with CVST were included. Their demographic, presenting symptoms and neurological findings were noted and risk factors of CVST were evaluated. The outcomes were assessed using modified Rankin Scale (mRS). Based on the risk factors, the patients could be categorized as proth...
6 CitationsSource
#1Aniket Prabhudesai (ICMR: Indian Council of Medical Research)H-Index: 2
#2Shrimati Shetty (ICMR: Indian Council of Medical Research)H-Index: 25
Last. Bipin Kulkarni (ICMR: Indian Council of Medical Research)H-Index: 11
view all 4 authors...
Abstract Cerebral venous thrombosis (CVT) is an uncommon neurological disease with high morbidity and mortality. Even after extensive thrombophilia screening, majority of the thrombosis cases remain with unknown etiology. Hypofibrinolysis due to acquired or congenital deficiencies or abnormalities in factors in the fibrinolytic cascade is a known cause of thrombosis at any site. In the present study 104 cases of radiologically confirmed CVT cases were investigated for the conventional thrombophi...
1 CitationsSource
#1José M. Ferro (University of Lisbon)H-Index: 95
#2Diana Aguiar de Sousa (University of Lisbon)H-Index: 11
Last. Sofia de Oliveira (University of Lisbon)H-Index: 15
view all 3 authors...
Cerebral venous thrombosis (CVT), an unusual form of stroke affecting the venous circulation rather than the more common arterial circulation, is being diagnosed with higher frequency due to increased awareness and ready access to MR. Multiple conditions have been reported in association with CVT. Risk factors and associated conditions for CVT can be categorized as permanent or transient. The most frequent permanent risk factors are genetic prothrombotic disorders. More than half of CVT patients...
Source
#1José M. Ferro (IMM: Instituto de Medicina Molecular)H-Index: 95
#2P. Canhão (IMM: Instituto de Medicina Molecular)H-Index: 17
Last. Diana Aguiar de Sousa (IMM: Instituto de Medicina Molecular)H-Index: 11
view all 3 authors...
An early diagnosis and heparin therapy have contributed to a decreased mortality in cerebral venous thrombosis (CVT). However, predictors of outcome are difficult to identify, because most studies suffered heterogeneity in diagnostic findings and treatments, retrospective design, and recruitment bias. The aim of this study was to evaluate the clinical outcome in 55 consecutive patients with CVT admitted over a 4-year period. The study population consisted of 42 women and 13 men, with a median ag...
22 CitationsSource
#1Joaquín V. Gonzalez (National University of Cuyo)H-Index: 1
#2Andrés G. Barboza (Facultad de Ciencias Médicas)H-Index: 2
Last. Esteban Gandara (Ottawa Hospital Research Institute)H-Index: 15
view all 4 authors...
Objectives To compare the prevalence of prothrombin G20210A in patients with objectively confirmed cerebral vein or cortical vein thrombosis against healthy controls, and evaluate geographical variations.
8 CitationsSource